Handbook of Medical Hallucinogens

Edited by Charles S. Grob and Jim Grigsby

Hardcovere-bookprint + e-book
Hardcover
March 9, 2021
ISBN 9781462545445
Price: $75.00
582 Pages
Size: 7" x 10"
order
e-book
January 29, 2021
ePub and PDF ?
Price: $75.00
582 Pages
order
print + e-book
Hardcover + e-Book (ePub and PDF) ?
Price: $82.50
582 Pages
order

Gabrielle Agin-Liebes, PhD, Department of Psychiatry and Behavioral Sciences, Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, California

Kenneth Alper, MD, Departments of Psychiatry and Neurology, New York University Grossman School of Medicine, New York, New York

Dráulio Barros de Araújo, PhD, Brain Institute, Federal University of Rio Grande do Norte, Natal, Brazil

Raquel Bennett, PsyD, KRIYA Institute, Berkeley, California

Michael P. Bogenschutz, PhD, Department of Psychiatry, New York University Grossman School of Medicine, New York, New York

Anthony P. Bossis, PhD, Department of Psychiatry, New York University Grossman School of Medicine, New York, New York

Gary Bravo, MD, KRIYA Institute, Berkeley, California

J. C. Callaway, PhD, Department of Medicinal Chemistry, University of Eastern Finland, Kuopio, Finland

Rob Colbert, PhD, The Nowak Society and Psychedelic Research and Training Institute, Fort Collins, Colorado

Mary Cosimano, LMSW, Center for Psychedelic and Consciousness Research, Johns Hopkins University School of Medicine, Baltimore, Maryland

Alan K. Davis, PhD, College of Social Work, The Ohio State University, Columbus, Ohio

Silvia Franco, MD, Department of Psychiatry, Columbia University and New York State Psychiatric Institute, New York, New York

Robert Grant, MD, MPH, Department of Pulmonary Medicine, School of Medicine, University of California, San Francisco, San Francisco, California; Healing Realms Psychotherapy, San Francisco, California

Jim Grigsby, PhD, Departments of Psychology and Medicine, University of Colorado Denver, Denver, Colorado

Shannon Hughes, PhD, School of Social Work, Colorado State University, Fort Collins, Colorado

Matthew W. Johnson, PhD, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland

Mendel Kaelen, PhD, Wavepaths, London, United Kingdom

David King, BSc, GKT School of Medical Education, King’s College London, London, United Kingdom

Rafael Lancelotta, MS, Habituating to Wholeness, Lakewood, Colorado

Benjamin Malcolm, PharmD, MPH,College of Pharmacy, Western University of Health Sciences, Pomona, California

Maria Mangini, PhD, FNP, School of Nursing, Holy Names University, Oakland, California

Ana Elda Maqueda, PhD, Xka Pastora, Madrid, Spain

Jonny Martell, MD, Centre for Psychedelic Research, Imperial College London, London, United Kingdom

Dennis J. McKenna, PhD, Heffter Research Institute, Santa Fe, New Mexico

Sarah E. Mennenga, PhD, Department of Psychiatry, New York University Grossman School of Medicine, New York, New York

Annie Mithoefer, BSN, MAPS Public Benefit Corporation, Santa Cruz, California

Michael Mithoefer, MD, FAPA, MAPS Public Benefit Corporation, Santa Cruz California; Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, South Carolina

Charles D. Nichols, PhD, Department of Pharmacology and Experimental Therapeutics, Louisiana State University Health Sciences Center, New Orleans, Louisiana

David E. Nichols, PhD, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina

Kristine Panik, MD, Counseling and Psychological Services, University of California, Berkeley, Berkeley, California

Torsten Passie, MD, PhD, Department of Psychiatry and Psychotherapy, Hannover Medical School, Hannover, Germany; Institute for History and Ethics in Medicine, Goethe University, Frankfurt am Main, Germany

David Presti, PhD, Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, California

Stevens Rehen, PhD, D’Or Institute, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil

Collin Reiff, PhD, Department of Psychiatry, New York University Grossman School of Medicine, New York, New York

Sidarta Ribeiro, PhD, Brain Institute, Federal University of Rio Grande do Norte, Natal, Brazil

William A. Richards, PhD, Center for Psychedelic and Consciousness Research, Johns Hopkins University School of Medicine, Baltimore, Maryland

Stephen Ross, MD, NYU Langone Health Program for Psychedelic Medicine, Department of Psychiatry, New York University Grossman School of Medicine, New York, New York

Emmanuelle A. D. Schindler, MD, PhD,Department of Neurology, Yale University School of Medicine, New Haven, Connecticut

Scott Shannon, MD, Psychiatric Research and Training Institute, Fort Collins, Colorado

Milan Scheidegger, MD, PhD,Department of Psychiatry, Psychotherapy and Psychosomatics, University Hospital of Psychiatry, Zurich, Switzerland

Candice L. Shelby, PhD, Department of Philosophy, University of Colorado Denver, Denver, Colorado

Enzo Tagliazucchi, PhD, Department of Physics, University of Buenos Aires, Buenos Aires, Argentina

Kelan Thomas, PharmD, MS, College of Pharmacy, Touro University California, Vallejo, California

Luís Fernando Tófoli, MD, PhD, School of Medical Sciences, University of Campinas, Campinas, Brazil

Will Van Derveer, MD, Integrative Psychiatry Institute, Boulder, Colorado

Michael Winkelman, MPH, PhD, School of Human Evolution and Social Change, Arizona State University, Tempe, Arizona